The DIA Global Meeting held in Boston from June 25-29, 2023, brought together professionals from the pharmaceutical industry, regulatory agencies, and research organisations. IMPALA was grateful to have a great delegation of members and to have three sessions to showcase some [...]
In the first few months since its launch, the Inter coMPany quALity Analytics (IMPALA) Consortium welcomes its newest BioPharma members: Amgen, AstraZeneca, Eli Lilly and Company, GSK, Galapagos, and Sanofi. IMPALA officially launched in October 2022 as a member program [...]
RQA features a session from IMPALA Consortium titled "Overview of IMPALA Industry Group and its impact on modernizing GCP/PV Quality." The session features Timothe Menard (Roche), Maria Brynildsen (Sanofi), and Michael Pelosi (Astellas). The session discusses the industry needs that [...]
IMPALA Consortium will be attending DIA 2023 in June in three sessions featuring speakers from member companies of IMPALA. we will have three sessions with speakers from companies that are members of the industry group. Check out the sessions below [...]
IEEE Spectrum, IEEE's leading magazine on technology and science, interviews IMPALA Consortium representatives on how the Consortium is bringing together leading pharmaceutical companies to streamline the QA process for drug approval.
